绞股蓝皂苷抗肿瘤活性成分及机制研究进展
Research Progress on Anti-Tumor Active Components and Mechanisms of Gypenosides
DOI: 10.12677/jcpm.2024.34322, PDF,    科研立项经费支持
作者: 刘梅玉*：赣南医科大学第一附属医院甲状腺疝外科，江西 赣州；赣州市甲状腺肿瘤重点实验室，江西 赣州；黄俊伟, 应 勇：赣南医科大学第一附属医院甲状腺疝外科，江西 赣州；廖海东：龙南市第一人民医院普外科，江西 赣州；曾祥泰#：赣南医科大学第一附属医院甲状腺疝外科，江西 赣州；龙南市第一人民医院普外科，江西 赣州
关键词: 绞股蓝皂苷；肿瘤；上皮–间充质转化；凋亡；细胞周期；Gypenosides； Cancer； Epithelial-Mesenchymal Transition； Apoptosis； Cell Cycle
摘要: 绞股蓝皂苷作为绞股蓝中的一种重要天然活性成分，近年来受到广泛关注。研究表明，绞股蓝皂苷具有多种生物活性，包括抗氧化、抗炎、降糖、降脂、心血管保护及免疫调节等作用，其中抗肿瘤活性尤为突出，可能与其调节细胞增殖、诱导凋亡、抑制肿瘤细胞转移等机制密切相关。对绞股蓝皂苷的抗肿瘤活性成分及作用机制进行了系统归纳和分析，旨在为绞股蓝皂苷在抗癌药理作用领域的进一步研究提供参考。
Abstract: Gypenosides, as an important natural active ingredient found in Gynostemma pentaphyllum, has received widespread attention in recent years. Studies have shown that gypenosides exhibit various biological activities, including anti-oxidant, anti-inflammatory, hypoglycemic, hypolipidemic, cardiovascular protection and immunomodulatory effects, among which the antitumour activity is particularly prominent, which may be closely related to its mechanisms of regulating cell proliferation, inducing apoptosis and inhibiting tumour cell metastasis. This article systematically summarizes and analyzes the anti-tumor bioactive components and mechanisms of gypenosides, aiming to provide reference and support for further research on their pharmacological effects in cancer treatment.
文章引用：刘梅玉, 黄俊伟, 廖海东, 应勇, 曾祥泰. 绞股蓝皂苷抗肿瘤活性成分及机制研究进展[J]. 临床个性化医学, 2024, 3(4): 2262-2269. https://doi.org/10.12677/jcpm.2024.34322

参考文献

[1] Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R.L., Soerjomataram, I., et al. (2024) Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 74, 229-263. [Google Scholar] [CrossRef] [PubMed]
[2] Kiri, S. and Ryba, T. (2024) Cancer, Metastasis, and the Epigenome. Molecular Cancer, 23, Article No. 154. [Google Scholar] [CrossRef] [PubMed]
[3] Wang, Y., Suarez, E.R., Kastrunes, G., de Campos, N.S.P., Abbas, R., Pivetta, R.S., et al. (2024) Evolution of Cell Therapy for Renal Cell Carcinoma. Molecular Cancer, 23, Article No. 8. [Google Scholar] [CrossRef] [PubMed]
[4] Butterfield, L.H. and Najjar, Y.G. (2023) Immunotherapy Combination Approaches: Mechanisms, Biomarkers and Clinical Observations. Nature Reviews Immunology, 24, 399-416. [Google Scholar] [CrossRef] [PubMed]
[5] 李倩, 陈雨萌, 王煦焱, 等. 绞股蓝的化学成分及其药理作用研究进展[J/OL]. 辽宁中医药大学学报, 1-20.
https://kns.cnki.net/kcms2/article/abstract?v=Mw9fkKjKljoG7GO54X-t0ffRfLven0hJ9DQJs7drKiLb9pbCvFx12HfJ4rQ54AxBJD7QOy5TKUEusy-y2jN9Q3Ac41bPEkHC94C61MUnBiY8kH22mDvm_HZOsl_MH57Liw3xObMJexG7ss4mpOEIZkthSNT0qFtOMrebqLuDWDU=&uniplatform=NZKPT, 2024-12-27.
[6] 杨册, 翟新房, 段宇, 等. 绞股蓝中皂苷类与黄酮类化合物的分离与鉴定[J]. 中华中医药杂志, 2022, 37(1): 401-406.
[7] Liang, H., Lu, P., Chu, L., Li, G., Li, C., Chen, X., et al. (2023) Dammarane-Type Saponins from Gynostemma pentaphyllum and Their Anti-Aging Activities via Up-Regulating Mitochondria Related Proteins. Phytochemistry, 213, Article ID: 113744. [Google Scholar] [CrossRef] [PubMed]
[8] Yue, S., Tan, Y., Zhang, L., Zhang, B., Jiang, F., Ji, G., et al. (2022) Gynostemma pentaphyllum Polysaccharides Ameliorate Non-Alcoholic Steatohepatitis in Mice Associated with Gut Microbiota and the TLR2/NLRP3 Pathway. Frontiers in Endocrinology, 13, Article 885039. [Google Scholar] [CrossRef] [PubMed]
[9] Zhang, H., Chen, X., Zong, B., Yuan, H., Wang, Z., Wei, Y., et al. (2018) Gypenosides Improve Diabetic Cardiomyopathy by Inhibiting ROS‐Mediated NLRP3 Inflammasome Activation. Journal of Cellular and Molecular Medicine, 22, 4437-4448. [Google Scholar] [CrossRef] [PubMed]
[10] Li, Y., Ouyang, Q., Li, X., Alolgal, R.N., Fan, Y., Sun, Y., et al. (2023) The Role of Gynostemma pentaphyllum in Regulating Hyperlipidemia. The American Journal of Chinese Medicine, 51, 953-978. [Google Scholar] [CrossRef] [PubMed]
[11] Cheng, T., Lu, J., Wang, J., Lin, L., Kuo, H. and Chen, B. (2011) Antiproliferation Effect and Apoptosis Mechanism of Prostate Cancer Cell PC-3 by Flavonoids and Saponins Prepared from Gynostemma pentaphyllum. Journal of Agricultural and Food Chemistry, 59, 11319-11329. [Google Scholar] [CrossRef] [PubMed]
[12] Wang, L., Peng, X., Ma, C., Hu, L., Li, M. and Wang, Y. (2024) Research Progress of Epithelial-Mesenchymal Transformation-Related Transcription Factors in Peritoneal Metastases. Journal of Cancer, 15, 5367-5375. [Google Scholar] [CrossRef] [PubMed]
[13] Lazar, A.M., Costea, D.O., Popp, C.G. and Mastalier, B. (2024) Skin Malignant Melanoma and Matrix Metalloproteinases: Promising Links to Efficient Therapies. International Journal of Molecular Sciences, 25, Article 7804. [Google Scholar] [CrossRef] [PubMed]
[14] Lu, K., Chen, J., Lai, T., Yang, J., Weng, S., Ma, Y., et al. (2010) Gypenosides Inhibits Migration and Invasion of Human Oral Cancer SAS Cells through the Inhibition of Matrix Metalloproteinase-2-9 and Urokinase-Plasminogen by ERK1/2 and NF-κB Signaling Pathways. Human & Experimental Toxicology, 30, 406-415. [Google Scholar] [CrossRef] [PubMed]
[15] Qi, Y., Xie, J., Xie, P., Duan, Y., Ling, Y., Gu, Y., et al. (2021) Uncovering the Anti-NSCLC Effects and Mechanisms of Gypenosides by Metabolomics and Network Pharmacology Analysis. Journal of Ethnopharmacology, 281, Article ID: 114506. [Google Scholar] [CrossRef] [PubMed]
[16] Huang, T.H., Tran, V.H., Roufogalis, B.D. and Li, Y. (2007) Gypenoside XLIX, a Naturally Occurring PPAR-α Activator, Inhibits Cytokine-Induced Vascular Cell Adhesion Molecule-1 Expression and Activity in Human Endothelial Cells. European Journal of Pharmacology, 565, 158-165. [Google Scholar] [CrossRef] [PubMed]
[17] Xiao, M., Pei, W., Li, S., Li, F., Xie, P., Luo, H., et al. (2024) Gypenoside L Inhibits Hepatocellular Carcinoma by Targeting the SREBP2-HMGCS1 Axis and Enhancing Immune Response. Bioorganic Chemistry, 150, Article ID: 107539. [Google Scholar] [CrossRef] [PubMed]
[18] Cui, C., Kim, D.J., Jung, S., Kim, S. and Im, W. (2017) Enhanced Production of Gypenoside LXXV Using a Novel Ginsenoside-Transforming β-Glucosidase from Ginseng-Cultivating Soil Bacteria and Its Anti-Cancer Property. Molecules, 22, Article 844. [Google Scholar] [CrossRef] [PubMed]
[19] Liu, H., Li, X., Duan, Y., Xie, J. and Piao, X. (2021) Mechanism of Gypenosides of Gynostemma pentaphyllum Inducing Apoptosis of Renal Cell Carcinoma by PI3K/AKT/mTOR Pathway. Journal of Ethnopharmacology, 271, Article ID: 113907. [Google Scholar] [CrossRef] [PubMed]
[20] Li, X., Liu, H., Lv, C., Du, J., Lian, F., Zhang, S., et al. (2022) Gypenoside-Induced Apoptosis via the PI3K/AKT/mTOR Signaling Pathway in Bladder Cancer. BioMed Research International, 2022, Article ID: 9304552. [Google Scholar] [CrossRef] [PubMed]
[21] Xing, S., Jang, M., Wang, Y. and Piao, X. (2016) A New Dammarane-Type Saponin from Gynostemma pentaphyllum Induces Apoptosis in A549 Human Lung Carcinoma Cells. Bioorganic & Medicinal Chemistry Letters, 26, 1754-1759. [Google Scholar] [CrossRef] [PubMed]
[22] Yan, H., Wang, X., Wang, Y., Wang, P. and Xiao, Y. (2013) Antiproliferation and Anti-Migration Induced by Gypenosides in Human Colon Cancer SW620 and Esophageal Cancer Eca-109 Cells. Human & Experimental Toxicology, 33, 522-533. [Google Scholar] [CrossRef] [PubMed]
[23] Yan, H., Wang, X., Niu, J., Wang, Y., Wang, P. and Liu, Q. (2014) Anti-Cancer Effect and the Underlying Mechanisms of Gypenosides on Human Colorectal Cancer SW-480 Cells. PLOS ONE, 9, e95609. [Google Scholar] [CrossRef] [PubMed]
[24] Zheng, Y., Zheng, Z., Ming, Y., Lin, M., Chen, L., Huang, W., et al. (2018) Gynosaponin TN-1 Producing from the Enzymatic Conversion of Gypenoside XLVI by Naringinase and Its Cytotoxicity on Hepatoma Cell Lines. Food and Chemical Toxicology, 119, 161-168. [Google Scholar] [CrossRef] [PubMed]
[25] Madhukar, G. and Subbarao, N. (2023) Potential Inhibitors of RPS6KB2 and NRF2 in Head and Neck Squamous Cell Carcinoma. Journal of Biomolecular Structure and Dynamics, 42, 1875-1900. [Google Scholar] [CrossRef] 
[26] Tran, T.N.A., Nahar, J., Park, J., Murugesan, M., Ko, J., Ahn, J.C., et al. (2024) Cloning, Characterization of β-Glucosidase from Furfurilactobacillus rossiae in Bioconversion and Its Efficacy. Archives of Microbiology, 206, Article No. 423. [Google Scholar] [CrossRef] [PubMed]
[27] Zu, M., Duan, Y., Xie, J., Qi, Y., Xie, P., Borjigidai, A., et al. (2021) Gypenoside LI Arrests the Cell Cycle of Breast Cancer in G0/G1 Phase by Down-Regulating E2f1. Journal of Ethnopharmacology, 273, Article ID: 114017. [Google Scholar] [CrossRef] [PubMed]
[28] Xing, S., Liu, L., Zu, M., Ding, X., Cui, W., Chang, T., et al. (2018) The Inhibitory Effect of Gypenoside Stereoisomers, Gypenoside L and Gypenoside LI, Isolated from Gynostemma pentaphyllum on the Growth of Human Lung Cancer A549 Cells. Journal of Ethnopharmacology, 219, 161-172. [Google Scholar] [CrossRef] [PubMed]
[29] Liu, J., Chiang, T., Wang, J., Lin, L., Chao, W., Inbaraj, B.S., et al. (2015) Induction of P53‐Independent Growth Inhibition in Lung Carcinoma Cell A549 by Gypenosides. Journal of Cellular and Molecular Medicine, 19, 1697-1709. [Google Scholar] [CrossRef] [PubMed]
[30] Song, H., Qiu, Z., Wang, Y., Xi, C., Zhang, G., Sun, Z., et al. (2023) Hif-1α/yap Signaling Rewrites Glucose/Iodine Metabolism Program to Promote Papillary Thyroid Cancer Progression. International Journal of Biological Sciences, 19, 225-241. [Google Scholar] [CrossRef] [PubMed]
[31] Pan, L., Lan, B., Li, S., Jin, Y., Cui, M., Xia, Y., et al. (2024) Gypenoside Inhibits Gastric Cancer Proliferation by Suppressing Glycolysis via the Hippo Pathway. Scientific Reports, 14, Article No. 19003. [Google Scholar] [CrossRef] [PubMed]
[32] 文利, 郑新, 刘飞, 等. 绞股蓝皂苷抑制HepG2细胞无氧糖酵解的检测分析[J]. 检验医学与临床, 2017, 14(4): 484-486.
[33] 谭先胜, 李锴男, 苗亚军. 绞股蓝皂苷通过上调sTim-3/Tim-3比率抑制非小细胞肺癌细胞免疫逃逸因子的表达[J]. 免疫学杂志, 2021, 37(6): 520-527.
[34] Wu, H., Lai, W., Wang, Q., Zhou, Q., Zhang, R. and Zhao, Y. (2024) Gypenoside Induces Apoptosis by Inhibiting the PI3K/AKT/mTOR Pathway and Enhances T-Cell Antitumor Immunity by Inhibiting PD-L1 in Gastric Cancer. Frontiers in Pharmacology, 15, Article 1243353. [Google Scholar] [CrossRef] [PubMed]
[35] Qi, Y., Xiao, M., Xie, P., Xie, J., Guo, M., Li, F., et al. (2022) Comprehensive Serum Metabolomics and Network Analysis to Reveal the Mechanism of Gypenosides in Treating Lung Cancer and Enhancing the Pharmacological Effects of Cisplatin. Frontiers in Pharmacology, 13, Article 1070948. [Google Scholar] [CrossRef] [PubMed]
[36] Ma, J., Hu, X., Liao, C., Xiao, H., Zhu, Q., Li, Y., et al. (2019) Gypenoside L Inhibits Proliferation of Liver and Esophageal Cancer Cells by Inducing Senescence. Molecules, 24, Article 1054. [Google Scholar] [CrossRef] [PubMed]
[37] Kong, L., Wang, X., Zhang, K., Yuan, W., Yang, Q., Fan, J., et al. (2015) Gypenosides Synergistically Enhances the Anti-Tumor Effect of 5-Fluorouracil on Colorectal Cancer in Vitro and in Vivo: A Role for Oxidative Stress-Mediated DNA Damage and P53 Activation. PLOS ONE, 10, e0137888. [Google Scholar] [CrossRef] [PubMed]
[38] Zhu, H., Liu, Z., Tang, L., Liu, J., Zhou, M., Xie, F., et al. (2012) Reversal of P-gp and MRP1-Mediated Multidrug Resistance by H6, a Gypenoside Aglycon from Gynostemma pentaphyllum, in Vincristine-Resistant Human Oral Cancer (KB/VCR) Cells. European Journal of Pharmacology, 696, 43-53. [Google Scholar] [CrossRef] [PubMed]